Expression of CD3E (a general T cell marker) clearly demarcated a subset of major and minor clusters, representing a substantial fraction of all cells of ~50% for melanoma PBMCs and >90% for the T zone lymphoma (Fig. 6a). This evidence concerns the gene CD3E and melanoma.